Strengthening Blood Regulatory Systems to Tackle Africa's Unmet Needs for Blood and Blood Products.
Africa
Blood safety
Hemovigilance
Regulation of blood and blood products
Journal
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie
ISSN: 1660-3796
Titre abrégé: Transfus Med Hemother
Pays: Switzerland
ID NLM: 101176417
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
15
07
2022
accepted:
14
11
2022
medline:
18
4
2023
entrez:
17
4
2023
pubmed:
18
4
2023
Statut:
epublish
Résumé
Assuring the quality and safety of blood and blood components is an essential element of health care in all countries and requires government commitment and legal frameworks. Ineffective regulation of blood and blood components has far-reaching consequences that are not limited to the affected countries but also have extensive global implications. In this review, we summarize the work of the project BloodTrain funded by the German Ministry of Health within the framework of the Global Health Protection Programme to strengthen regulatory structures in Africa that are imperative to guarantee the improved availability, safety, and quality of blood and blood products. Intense interaction with the stakeholders in African partner countries lead to first measurable successes in the strengthening of blood regulation, as shown here for hemovigilance.
Sections du résumé
Background
UNASSIGNED
Assuring the quality and safety of blood and blood components is an essential element of health care in all countries and requires government commitment and legal frameworks. Ineffective regulation of blood and blood components has far-reaching consequences that are not limited to the affected countries but also have extensive global implications.
Summary
UNASSIGNED
In this review, we summarize the work of the project BloodTrain funded by the German Ministry of Health within the framework of the Global Health Protection Programme to strengthen regulatory structures in Africa that are imperative to guarantee the improved availability, safety, and quality of blood and blood products.
Key Messages
UNASSIGNED
Intense interaction with the stakeholders in African partner countries lead to first measurable successes in the strengthening of blood regulation, as shown here for hemovigilance.
Identifiants
pubmed: 37066057
doi: 10.1159/000528077
pii: tmh-0050-0123
pmc: PMC10090969
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
123-128Informations de copyright
Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
BMJ Glob Health. 2020 Aug;5(8):
pubmed: 32784212
Lancet Haematol. 2019 Dec;6(12):e598-e599
pubmed: 31631024
Front Med (Lausanne). 2020 Aug 19;7:457
pubmed: 32974367
Biologicals. 2012 May;40(3):200-4
pubmed: 22122986
BMC Health Serv Res. 2021 Nov 20;21(1):1258
pubmed: 34801022
Biologicals. 2020 Nov;68:125-128
pubmed: 32907761
Lancet Haematol. 2019 Dec;6(12):e606-e615
pubmed: 31631023
J Pharm Policy Pract. 2020 Oct 05;13:64
pubmed: 33029353